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Abstract
Background: Flaxseed (FS) is a dietary supplement known for its antioxidant and anti-inflammatory properties.
Radiation exposure of lung tissues occurs either when given therapeutically to treat intrathoracic malignancies or
incidentally, such as in the case of exposure from inhaled radioisotopes released after the detonation of a
radiological dispersion devise (RDD). Such exposure is associated with pulmonary inflammation, oxidative tissue
damage and irreversible lung fibrosis. We previously reported that dietary FS prevents pneumonopathy in a rodent
model of thoracic X-ray radiation therapy (XRT). However, flaxseed’s therapeutic usefulness in mitigating radiation
effects post-exposure has never been evaluated.
Methods: We evaluated the effects of a 10%FS or isocaloric control diet given to mice (C57/BL6) in 2 separate
experiments (n = 15-25 mice/group) on 0, 2, 4, 6 weeks post a single dose 13.5 Gy thoracic XRT and compared it
to an established radiation-protective diet given preventively, starting at 3 weeks prior to XRT. Lungs were
evaluated four months post-XRT for blood oxygenation levels, inflammation and fibrosis.
Results: Irradiated mice fed a 0%FS diet had a 4-month survival rate of 40% as compared to 70-88% survival in
irradiated FS-fed mouse groups. Additionally, all irradiated FS-fed mice had decreased fibrosis compared to those
fed 0%FS. Lung OH-Proline content ranged from 96.5 ± 7.1 to 110.2 ± 7.7 μg/ml (Mean ± SEM) in all irradiated FS-
fed mouse groups, as compared to 138 ± 10.8 μg/ml for mice on 0%FS. Concomitantly, bronchoalveolar lavage
(BAL) protein and weight loss associated with radiation cachexia was significantly decreased in all FS-fed groups.
Inflammatory cell influx to lungs also decreased significantly except when FS diet was delayed by 4 and 6 weeks
post XRT. All FS-fed mice (irradiated or not), maintained a higher blood oxygenation level as compared to mice on
0%FS. Similarly, multiplex cytokine analysis in the BAL fluid revealed a significant decrease of specific inflammatory
cytokines in FS-fed mice.
Conclusions: Dietary FS given post-XRT mitigates radiation effects by decreasing pulmonary fibrosis, inflammation,
cytokine secretion and lung damage while enhancing mouse survival. Dietary supplementation of FS may be a
useful adjuvant treatment mitigating adverse effects of radiation in individuals exposed to inhaled radioisotopes or
incidental radiation.
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Ionizing radiation produces deleterious effects in living
organisms. Rapid technological advancement has
increased human exposure to ionizing radiations. People
are exposed to ionizing radiation during diagnostic and
therapeutic radiographic procedures, as well as in their
daily activities at the work place [1]. Humans are also
exposed to ionizing radiation during air and space tra-
vel, background radiation from nuclear accidents and
through the use of electronic devices. Additionally, glo-
bal developments of the past decade have established
terrorism as a novel and highly concerning means by
which large numbers of people could be exposed to
potentially lethal amounts of radiation [2].
There are at least two potential ways that a terroristic
attack could expose a population to radiation injury. If
terrorists gained possession of a nuclear warhead, deto-
nation could release large amounts of radiation (in a
single “blast”) that could induce radiation sickness, bone
marrow damage and potential lung injury. More likely,
however, the weapon of radiological terrorism would be
a “dirty bomb”, or a radiological dispersion device
(RDD). In a RDD, conventional explosives would spread
radioactive materials in the form of powder or pellets
[2-4] which can spread far away from the immediate
explosion and pose a high health risk if inhaled. Expo-
sure to whole-body irradiation induces the well defined
acute radiation syndrome (ARS), with symptoms from
damage to hematopoietic, gastrointestinal and central
nervous system [5]. However, in detonation of a RDD,
the lung becomes the critical target organ for radiation
injury.
Radiation pneumonopathy has been well characterized
as a significant clinical toxicity from thoracic radiation
[6,7]. Patients receiving large doses of radiation to the
lung show two types of adverse clinical scenarios [8]. An
acute type of radiation pneumonopathy can occur as
early as two weeks after irradiation whereby a “pneumo-
nitic” or exudative reaction occurs. In the second type
of radiation-induced lung injury, occurring within sev-
eral months after exposure, the lung tissue enters the
“late fibrotic” phase, in which the number of inflamma-
tory cells (particularly neutrophils) decrease and a
marked thickening of alveolar walls due to collagen
deposition can be noted histopathologically. Radiation
pneumonopathy has been modeled in animals; the C57/
BL6 mice are especially susceptible to this fibrotic reac-
tion [9-11].
Several agents, ranging from cytokines to receptor
blockers, have been tested for their efficacy in ameliorat-
ing radiation effects [10,12-14]. Unfortunately most
agents, even those proven to be effective as radioprotec-
tors (i.e., tested prior to a radiation exposure), are not
yet available for human use. Additionally, these agents
were intended as treatments for injuries resulting from
the therapeutic use of radiation which is a very different
scenario than radiation injuries resulting from nuclear
accidents or radiological terrorism. Specifically, in most
accident or terrorism scenarios, a) treatment would not
be able to be initiated until after the irradiation, there-
fore, eliminating agents that work only when given
before irradiation; b) the radiation would be received in
a short overall time and there might be agents that are
effective with multi-week radiation treatments that are
less effective for a single large dose of radiation and c) a
potential mitigator would need to be administered to a
large population of healthy individuals exposed to an
undetermined dose of radiation, making it highly desir-
able to find a agent that is non-toxic and safe for multi-
ple administrations lasting throughout the long
exposure and recovery phase.
High toxicity and unwanted side effects associated
with chemical radioprotectors (thiols, antioxidant
enzymes, etc) [15,16], has shifted the focus to the eva-
luation of the radioprotective potential of plants and
h e r b sa sw e l la sa n t i o x i d a n ta g e n t s[ 1 7 ] .O u rg r o u ph a s
identified flaxseed and its bioactive lignan component as
potent protectors against radiation-induced lung toxicity
when given prior to radiation exposure [11]. Specifically,
dietary flaxseed decreased radiation-induced oxidative
lung tissue damage, decreased lung inflammation and
prevented lung fibrosis. This study was performed to
determine whether dietary flaxseed can also be effective
as a mitigator of radiation toxicity, i.e., when adminis-
tered after radiation exposure to the lung.
Methods
Animals
Our studies used female C57/BL6 mice, a strain well
characterized in the field of pulmonary radioprotection
[18,19]. Mice were obtained from Charles River (Wil-
mington, MA) and irradiated at 6-8 weeks of age under
animal protocols approved by the Institutional Animal
Care and Use Committee (IACUC) of the University of
Pennsylvania. For this study we used n = 15 for each of
the non-irradiated control groups (0%FS and 10%FS)
and n = 25 for each of the irradiated mouse cohorts.
The data shown here represent combined data from two
separate studies.
Diets and dietary treatments
Semi-purified AIN-93G diet was used as the base diet
which was supplemented with 10% (w/w) FS as
described in our previous publications [11,20]. Control
and experimental diets were isocaloric and identical in
Physsiological fuel value. Whole ground yellow FS (Lot#
1012338) was kindly provided by Dr. James Hammond
(North Dakota State University, Fargo, ND). Diets were
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maintained on the respective diets for the entire dura-
tion of the experiment until termination at 4 months
post-radiation exposure.
Radiation procedure
Mice were anesthetized and irradiated as previously
described [10]. Briefly, using an immobilization chamber
that allows bilateral exposure of the lung of up to 8
mice simultaneously while lead shielding (3 mm) the
head, abdomen and extremities, 13.5 Gy was delivered
to mid-plane using a 250 kVp orthovoltage machine
(Philips RT 250) at a dose/rate of 1.7 Gy/min and a
source to skin distance of 33 cm, through a 0.2 mm
copper filter and a tube current of 13 mA. For quality
assurance, thermoluminescent dosimeters were placed
over selected mice to verify correct dose administration.
Analytical evaluation of lignan content in murine plasma
Circulating plasma levels of the flaxseed lignans ED and
EL at time of sacrifice (4 months post-XRT) were deter-
mined by liquid chromatogra Phys tandem mass spec-
trometry (LC/MS/MS) as described earlier [21,22] using
commercially available standards in 95% purity (Chro-
madex, Inc., Santa Ana, CA). Plasma flaxseed lignan
levels were evaluated in 3 randomly selected mice per
group (irradiated mice; diet initiated at -3, 0, +2, +4, +6
weeks of radiation exposure).
Bronchoalveolar lavage fluid analysis
Mice were sacrificed using an overdose of ketamine (100
mg/ml) and xylazine (20 mg/ml) at 4 months post-irra-
diation. Bronchoalveolar lavage (BAL) was then per-
formed through a 20-gauge angiocatheter (BD
Pharmingen, San Diego, CA), with the intra-tracheal
instillation of 1 ml phosphate-buffered saline (PBS) con-
taining an anti-protease cocktail (Sigma) and 5 mM
EDTA given in 0.5 ml increments. An aliquot was
immediately separated to measure total leukocyte cell
counts (cells/ml BAL fluid) using a Coulter Cell and
Particle Counter (Beckman Coulter, Miami, FL). The
remaining lavage fluid was centrifuged at 1,200 rpm for
10 min and the cell-free supernatant was frozen at -80°
C for cytokine and protein analysis.
The amount of total protein in the BAL fluid was
assayed using the BCA Protein Assay Kit (Pierce, Rock-
ford, IL) as per manufacturer’s instructions. Absorbance
was read at 560 nm (MRX Microplate Reader, Dynatech
Laboratories, Chantilly, VA) and protein levels in mg/ml
of BAL fluid were calculated.
Multiplexed cytokine analysis
The cytokine concentrations in the BAL fluid were assayed
using Invitrogen’s Mouse Cytokine 20-Plex Panel
(LMC0006). This panel permits simultaneous quantifica-
tion of multiple cytokines in solution by capturing them
onto antibody coated spectrally distinct fluorescent micro-
spheres and measuring fluorescence intensity using the
BioPlex 200 (Bio-Rad Laboratories, Hercules, CA) system.
The kit quantified 20 mouse cytokines and chemokines:
FGF-basic, Granulocyte Macrophage Colony-Stimulating
Factor (GM-CSF), interferon-g (IFN-g), Interleukin (IL)-
1a,I L - 1 b,I L - 2 ,I L - 4 ,I L - 5 ,I L - 6 ,I L - 1 0 ,I L - 1 2( p 4 0 / p 7 0 ) ,
IL-13, IL-17, IP-10, keratinocyte-derived chemokine (KC),
Monocyte Chemoattractant Protein-1 (MCP-1), Macro-
phage Inflammatory Protein-1a (MIP-1a), MIG, Tumor
Necrosis Factor-a (TNF-a) and vascular endothelial
growth factor (VEGF). The assay was performed according
to the manufacturer’s protocol. All the samples were run
in duplicate. The detection limit of this kit is in pg/ml for
all the included cytokines.
Tissue harvesting and evaluation of oxidative lung injury
Radiation experiments were terminated after 16 weeks,
corresponding to a time point when radiation-induced
fibrosis is readily detectable in our model [10,21,22]
using both biochemical assays and histopathological eva-
luation. For histological studies, the lungs were instilled
prior to removal from the animal with 0.75 ml of buf-
fered formalin through a 20-gauge angiocatheter placed
in the trachea, immersed in buffered formalin overnight
and processed for conventional paraffin histology. Sec-
tions were stained with hematoxylin and eosin and
examined by light microscopy. Malondialdehyde (MDA),
an indicator of oxidative stress [23] was measured in
homogenized lung tissues using a commercially available
kit (OXIS International, Portland, OR) according to
manufacturer’s protocol. The results were expressed as
μmol MDA/g of lung protein.
Oxygen saturation measurements
We used a mouse-adapted Pulse-oximeter (Starr Life
Sciences, Oakmont, PA) as a non-invasive clinical
Figure 1 Experimental Plan. Mice were fed with 0% or 10%FS diet
initiated prior (-3 weeks) or post (+2, +4, +6 weeks) single fraction
(13.5 Gy) X-ray radiation therapy (XRT). Mice were sacrificed at 4
months post-XRT.
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were shaved around the neck area to remove black hair
that interfered with detection and a pulse-oximeter clip
was placed on the neck, over the carotid arteries. Mice
were allowed to walk freely in a small chamber covered
by a light blocking fabric supplied by the manufacturer.
In some instances, mice were pre-adapted to the feeling
of the neck sensor collar by adding a mock collar on
them for a day prior to evaluation. Three minute read-
ings were taken from each mouse, measurements con-
taining error codes were removed and the average of
the remaining readings was calculated (usually those
ranged from 1000-3000). On a limited number of mice,
arterial blood gas analysis of carotid blood was per-
formed using an i-STAT blood gas analyzer (Abbott
Laboratories, East Windsor, NJ) using G3+ cartridges
and results compared to those from pulse oximetry.
Quantitative and semi-quantitative assessment of fibrosis
Collagen content of mouse lung was evaluated quantita-
tively by determining hydroxy-proline (OH-Proline) con-
tent using acid hydrolysis [10] according to Woessner et
al. [25]. The data is expressed as μg hydroxyproline/
whole lung. Semi-quantitative evaluation of fibrosis was
done histologically by determining a radiation Fibrotic
Index (FI) as described previously [22].
Statistical analysis
Results are expressed as mean ± SEM of two indepen-
dent experiments. Statistical differences among groups
were determined using one-way analysis of variance
(ANOVA). When statistically significant differences
were found (p < 0.05) individual comparisons were
made using the Bonferoni/Dunn test (Statview 4.0). We
used the Cox proportional-hazard model with a time-
varying predictor to evaluate the effect of FS administra-
tion on animal survival (Proc Phreg; SAS Version 9.2;
SAS Institute, Cary, NC).
Results
Detection of lignan content in murine plasma
Analytical methods (LC/MS/MS) were used to detect
flaxseed metabolites in the circulation to confirm that
mice fed on the flaxseed-supplemented diet were reach-
ing Physsiologically relevant levels, comparable to those
in all our previous studies [11,20,22]. Mice were main-
tained on control (0%FS) or treatment (10%FS) diets
given ad libitum for either three weeks prior to XRT or
started on same day of XRT or 2,4,6 weeks post XRT
and continued for 4 months (see scheme on Figure 1).
Plasma evaluation for lignan level detection was done at
16 weeks post XRT.
Indeed (Figure 2), although variable, both ED and EL
were detectable in all FS-fed mouse groups 4 months
post-irradiation while no ED or EL was detectable in the
control-diet fed mice. Levels of ED and EL ranged from
14-405 ng/ml and 103-325 ng/ml of plasma, respec-
tively. These values fall within the reported range for
our studies in other models of acute and chronic lung
injury [11,20,22].
Figure 2 Detection of flaxseed lignan metabolites in blood. Circulating lignan (ED and EL) levels in plasma of mice, 4 months post-XRT,
were determined using GC/MS/MS. Mice were fed with 0% or 10%FS diet initiated prior (-3 weeks) or post (+2, +4, +6 weeks) X-ray radiation
therapy (XRT). Data is represented mean ± SEM (n = 3 mice per group).
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induced cachexia and boosts survival
Radiation-induced pneumonopathy is associated with
cachexia measured by loss in body weight. We therefore
evaluated the effect of post-irradiation administration of
10%FS diet on XRT-induced loss in body weight (Figure
3) and survival (Figure 4) of mice. Although designed to
be isocaloric, the 10%FS diet given to non-irradiated
mice led to a significant (p < 0.007) difference in body
weight (28.2 ± 1.07 g) as compared to non-irradiated
mice on the 0%FS, control diet (23.8 ± 0.83 g). A fair
comparison, therefore, of dietary treatments (0% vs.
10%) would be to compare each diet regimen with the
non-irradiated counterparts. As anticipated, XRT
decreased the body weight (18.9 ± 1.37 g) of animals
on the 0% control diet significantly (p ≤ 0.01) as com-
pared with their non-irradiated counterparts. Remark-
ably, the 10%FS supplementation, whether given 3
weeks prior to irradiation or several weeks thereafter,
significantly prevented XRT-induced weight loss. The
only exception was the condition where diet was
initiated on the day of irradiation. In this group, the
body weight was not significantly different than the 0%
F Sf e di r r a d i a t e dg r o u p .
XRT (13.5 Gy, 0%FS)-induced radiation sickness and
early mortality was observed in all groups, albeit to vari-
able degree, within the first 2-3 weeks of exposure (Fig-
ure 4A). We have observed this effect previously, and
attributed this early death to poor oral intake possibly
from esophagitis. Later deaths, occurring in 8-16 weeks
are attributed to radiation pneumonopathy. However, by
4 months post XRT, only 40% of animals survived in
the irradiated group (0%FS), as compared to the non-
irradiated counterparts (Figure 4B). These values fall
w i t h i nt h ep r e v i o u s l yo b s e r v e ds u r v i v a lr a t e[ 2 2 ] ,g i v e n
that the selected dose of 13.5 Gy reflects the LD50 as
shown in our previous studies. Interestingly, 10%FS diet
led to a significant (p < 0.05) increase in the survival of
animals in all groups when compared with irradiated
g r o u p( X R T ,0 % F S ) .W h e n1 0 % F Sd i e tw a ss t a r t e dp r e -
ventively, i.e., 3 weeks prior to XRT, survival was
enhanced significantly (80%; p < 0.05) in comparison to
irradiated group, a finding in agreement with previous
observations. Remarkably, flaxseed diet, when given
therapeutically, i.e., initiated post-XRT, enhanced the
survival of all irradiated animal groups. When 10%FS
diet was given to animals up to 6 weeks post-irradiation,
animal survival increased significantly (p < 0.05).
Figure 3 Effect of Flaxseed (FS) diet on body weight of mice 4 months post-XRT. Mice were fed with 0% or 10%FS diet prior (-3 weeks) or
post (+2, +4, +6 weeks) X-ray radiation therapy (XRT). Body weight was recorded at 4 months post-irradiation. Data is represented mean ± SEM
of two independent experiments (n = 15-25 mice per group). The white, black, gray and hatched bars represent untreated control, 0%FS + XRT,
10%FS and 10%FS + XRT groups, respectively. The dotted line represents weight average in non-irradiated control animals. *p ≤ 0.01 for
irradiated 0%FS vs. irradiated 10%FS,
$p ≤0.01 for irradiated vs. non-irradiated 0% and #p ≤ 0.05 irradiated 10%FS (initiated 3 weeks prior to XRT)
vs. all irradiated 10%FS (diet initiated on, or post-XRT).
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hemodynamics and mitigates pulmonary inflammation
and oxidative lung injury
Thoracic radiation is associated with pneumonopathy
characterized by inflammatory cell influx and pulmonary
edema. We have previously shown that preventive use of
dietary FS decreased radiation-induced lung damage and
inflammation [22]. To test whether FS also mitigates
these effects when administered at variable times post
radiation challenge, we delayed the dietary administra-
tion (0, 2, 4, 6 weeks) and evaluated BAL at 4 months
post-XRT. We confirmed BAL findings with a histo-
pathological evaluation of lungs in mice belonging in
the same groups of mice, which, however, were not
lavaged, so that histological evaluation would not be
compromised.
We observed a significantly reduced inflammatory cell
influx (Figure 5A) in the BAL fluid from lungs in all
irradiated mouse groups fed with 10%FS diet as com-
pared with those on control diet, regardless of the time
the diet was initiated (pre- or post-XRT). Alveolar pro-
tein level is a marker for increased lung permeability
and lung injury. Alveolar protein exudate was increased
37-fold (3.78 ± 1.19 mg/ml) in mice 4 months post-
XRT (Figure 5B) in comparison to untreated controls
(0.1 ± 0.013 mg/ml). These findings correlated with the
histopathological evaluation (Figure 6). In summary, FS
diet significantly (p < 0.05) decreased lung injury and
edema by decreasing the XRT-induced alveolar protein
levels irrespective of therapeutic or preventive
administration.
Radiation pneumonopathy is also associated with com-
promised pulmonary function resulting in poor oxyge-
nation levels as modeled in rodent models [26]. Pulse
oximetry is a non-invasive way of determining arterial
blood oxygenation levels (Figure 5C). XRT notably
decreased the percentage of arterial O2 levels (61.4% ±
10.77%) in mice fed with 0% control diet in comparison
to untreated control animals (78.5% ± 5.33%). Mice Fed
with 10%FS diet had an increase percentage of arterial
O2 levels compared to mice fed 0% diet following XRT.
FS diet enhanced blood oxygenation, thus improving
pulmonary hemodynamics in irradiated mice irrespective
of whether it was given therapeutically or preventively.
Dietary FS mitigates oxidative lung changes when given
post-thoracic XRT
Lipid peroxidation plays a major role in mediating oxi-
dative-damage in tissues. Thoracic radiation-induced
oxidative degradation of unsaturated fatty acids can be
followed by determining the amount of a product, mal-
ondialdehyde (MDA), of lipid peroxidation in lung tis-
sues [21,22]. A significant two-fold increase in MDA
levels was recorded in irradiated animals fed with
c o n t r o ld i e ta sc o m p a r e dt ou n c h a l l e n g e dc o n t r o l s( F i g -
ure 7). In contrast, mice fed with a 10%FS diet (whether
given preventively or therapeutically) maintained a sig-
nificantly (p ≤ 0.005) lower MDA level at 4 months
post-XRT in all the treatment groups (diet initiated -3
or 0,2,4,6 weeks post XRT) as compared to irradiated
mice fed with 0%FS diet. Importantly, no statistical dif-
ference was found among any of the irradiated FS-fed
groups (Figure 7, hatched bars) and the non-irradiated
FS group (Figure 7, grey bar).
Dietary FS mitigates fibrotic changes in lung tissue when
given post-thoracic XRT
Dietary flaxseed prevents radiation-induced pulmonary
fibrosis in mice when given preventively [22]. However,
its effects when given therapeutically, i.e., post the radia-
tion challenge, are unknown. To test this, we evaluated
the total OH-Proline content of murine lungs 4 months
post-XRT (Figure 8A). This is a quantitative measure of
collagen deposition and fibrosis in lungs, which is
expressed as μg OH-proline/lung. XRT led to a signifi-
cant (p ≤ 0.0001), near 2-fold increase of OH-Proline in
mice (0%FS) in comparison to unchallenged controls. FS
diet rendered a noteworthy decline in OH-Proline levels
in all radiation-challenged mice. Mice fed with 10%FS
diet prior or post-XRT had significantly (p ≤ 0.005)
deceased levels of OH-Proline content in comparison to
those fed with 0%FS following XRT (Figure 8A).
To further evaluate the degree of XRT-induced fibro-
sis and correlate biochemical findings with tissue histol-
ogy, lungs were also examined histolopathologically
using Trichrome staining (Figure 9) and Fibrotic Index
(FI) score, a measure of the extent of lung fibrosis and
inflammation, was determined for each lung (Figure 8B).
Lungs of irradiated mice fed with 0%FS diet showed
severe fibrosis (Figure 9B, blue color) as compared to
non-irradiated mice (0%FS). The extent of fibrosis was
notably reduced in all animal groups fed with 10%FS
diet prior or post-XRT when compared to irradiated 0%
FS fed mice.
Alterations of pro-inflammatory and pro-fibrotic cytokine
profile in the BAL fluid of FS-fed mice 4 months post-XRT
Thoracic radiation-induced cytokines, chemokines and
cell adhesion molecules are implicated in the pathogen-
esis of pulmonary inflammation, both subacute and
chronic, as well as in the development of lung fibrosis
[27]. To determine the beneficial effects of FS given sev-
eral weeks post radiation challenge, we evaluated inflam-
matory cytokine levels in BAL fluid in mice sacrificed 4
months post XRT (Table 1). This time coincides with
radiation pneumonitis and the onset of detectable lung
fibrosis. Using multiplex cytokine analysis, we analyzed
the effect of FS on a panel of 20 cytokines. While half
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Page 6 of 15Figure 4 Effect of Flaxseed (FS) diet on the survival of mice 4 months post-XRT. Mice were fed with 0% or 10%FS diet prior (-3 weeks) or
post (+2, +4, +6 weeks) X-ray radiation therapy (XRT) and observed for survival up to 16 weeks post-irradiation. Data is represented mean ± SEM
of two independent experiments (n = 15 and 25 mice in non-irradiated and irradiated groups, respectively). Panel A: Kinetics of mouse survival.
Panel B: Mouse survival 4 months post-XRT. The white, black, gray and hatched bars represent untreated control, 0%FS + XRT, 10%FS and 10%
FS + XRT groups, respectively.
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Page 7 of 15Figure 5 Evaluation of Lung Injury, Inflammation and Blood Oxygenation Levels in mice 4 months post-XRT. Mice were fed with 0% or
10%FS diet at designated times (-3, 0, +2, +4, +6 weeks) of X-ray radiation therapy (XRT). Data is represented mean ± SEM of two independent
experiments (n = 15-25 mice per group). Panel A: Total WBC counts in bronchoalveolar lavage (BAL) of irradiated (13.5 Gy, XRT) mice after 4
months. *p ≤ 0.05 for irradiated 0%FS vs. irradiated 10%FS Panel B: Total proteins in BAL of mice after 4 months. *p ≤ 0.01 for irradiated 0%FS
vs. irradiated 10%FS Panel C: Arterial O2 levels were measured using pulse oximetry in irradiated (13.5 Gy, XRT) mice after 4 months. The white,
black, gray and hatched bars represent untreated control, 0%FS + XRT, 10%FS and 10%FS + XRT groups, respectively. *p ≤ 0.05 for irradiated 0%
FS vs. irradiated 10%FS.
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MCP-1, TNF-a) were at levels below the detection limit
of the assay, 10 cytokines (IL1b, IL-2, IL-4, IL-6, IL-12,
IL-17, IP-10, KC, MIG, MIP-a and VEGF) were measur-
able in the BAL fluid of all mouse groups.
A significant decrease in the levels of IL-1b, IL-2, IL-4,
MIG, or MIP-1a was detected in all of the irradiated FS
diet fed groups as compared to irradiated mice on con-
trol diet. However, levels of IL-6, IL-12, IL-17 and
VEGF were significantly lower in irradiated FS-fed mice
as compared to irradiated mice on control diet. Notably,
even delaying FS diet by as long as 6 weeks post-radia-
tion challenge resulted in a several-fold decrease of the
above-mentioned cytokines.
Discussion
We demonstrate here for the first time the role of FS in
boosting survival and mitigating the acute and chronic
Figure 6 Histological evaluation of lung Hematoxylin and Eosin (H&E)-stained sections post-XRT (4 months). Mice were fed with 0% or
10%FS diet prior (-3 weeks) or post (+2, +4, +6 weeks) X-ray radiation treatment (XRT). Lungs were harvested 4 months post single fraction XRT
and processed for histology. Asterisks designate proteinaceous exudate in alveolar spaces.
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sues when administered days and even weeks after
radiation exposure. Results from our study show that FS
significantly ameliorates the XRT-induced damage by
improving survival and body weight of mice fed with FS
not only when diet was given prior to XRT but also
when diet was started 2, 4 and 6 weeks after XRT. We
also found that FS diet mitigated the deleterious effects
of XRT by: a) improving pulmonary hemodynamics and
blood oxygenation levels, b) decreasing lung injury by
lowering BAL protein levels, c) reducing pulmonary
fibrosis by decreasing collagen content of lung tissues,
d) reducing lung inflammation by decreasing WBC
influx into the airways and by e) oxidative modification
of mouse lungs as evidenced by levels of lipid peroxida-
tion. BAL cytokine analysis, moreover, pointed to an
alteration of the chronic inflammatory profile of irra-
diated lungs favoring a mitigated radiation effect as a
result of the FS diet.
Some reports suggest using lung lavage to remove
radionuclides inhaled after a dirty bomb detonation as a
possible countermeasure [28,29]. However, this remains
an impractical countermeasure since multiple lavages
may be required for efficient removal of radionuclide
burden while the procedure itself is associated with
known risks of an invasive procedure that requires
anesthesia. Alternatively, a plethora of compounds both
chemical/natural are being evaluated with the intent of
mitigating radiation damage [17]. To date Amifostine is
the only FDA approved cytoprotective radiation
mitigator. However, the use of Amifostine has been lim-
ited by its significant systemic toxicity [17]. Further,
most of the compounds that offered a positive radiopro-
tection on cells have not shown efficacy in pre-clinical
animal studies.
An ideal radiation mitigator should be safe, effective,
have a long shelf life and an easy route of administra-
tion. Flaxseed, due to its high content of lignans and
omega-3 fatty acids, is a dietary supplement that has
numerous medicinal, anti-inflammatory and antioxidant
properties. FS and its bioactive components have been
extensively studied for their anti-inflammatory [11,20],
anticarcinogenic [30,31] and anti-atherogenic effects
[32] in several organ systems. Importantly, prolonged FS
administration has not been associated with any signifi-
cant toxicity [33]. Therefore, we hypothesized that flax-
seed may be an effective, safe and cost-effective
mitigator of the radiation damage.
Our data showed that 10%FS diet supplementation
significantly increased the survival in mice in all the
irradiated groups (Figure 4) irrespective of the time of
initiation of the FS diet (70-88% survival) as compared
to the survival of mice fed with 0%FS diet (40% survi-
val). It is evident from our results that FS diet protects
mice from XRT-induced mortality whether given thera-
peutically or preventively. Improvement of survival
using antioxidants such as N-acetyl-Cysteine (NAC) or
mitochondrion-targeted small molecule radiation
damage mitigators has been shown in mouse models of
abdominal irradiation [34] or total body irradiation [35]
Figure 7 Effect of 10%FS diet on lung lipid peroxidation levels 4 months post-XRT. Mice were fed with 0% or 10%FS diet prior (-3 weeks)
or post (+2, +4, +6 weeks) X-ray radiation therapy (XRT). Lungs were harvested after 4 months, homogenized and assayed for lipid peroxidation
by measuring Malondialdehyde (MDA) levels. MDA is calculated per g of wet lung tissue. Data is represented mean ± SEM of two independent
experiments (n = 15-25 mice per group). The white, black, gray and hatched bars represent untreated control, 0%FS + XRT, 10%FS and 10%FS +
XRT groups, respectively. *p ≤ 0.0002 for irradiated 0%FS vs. irradiated 10%FS.
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Page 10 of 15Figure 8 Determination of fibrotic changes in mouse lungs 4 months post-XRT. Panel A: Evaluation of OH-Proline content in lungs of
irradiated (13.5 Gy, XRT) mice. Mice were fed with 0% or 10%FS diet prior (-3 weeks) or post (+2, +4, +6 weeks) XRT. Lungs were harvested after
4 months and OH-Proline assay was performed. *p ≤ 0.005 for irradiated 0%FS vs. irradiated 10%FS. Panel B: Fibrotic Index range = 0 - 4). Data
is represented mean ± SEM of two independent experiments (n = 15-25 mice per group). The white, black, gray and hatched bars represent
untreated control, 0%FS + XRT, 10%FS and 10%FS + XRT groups respectively. *p ≤ 0.005 for irradiated 0%FS vs. irradiated 10%FS. *p ≤ 0.005 for
irradiated 0%FS vs. irradiated 10%FS.
Christofidou-Solomidou et al. BMC Cancer 2011, 11:269
http://www.biomedcentral.com/1471-2407/11/269
Page 11 of 15respectively. To our knowledge our study is the first to
report that a mitigator of radiation damage improves
survival of animals in an experimental model of thoracic
radiation damage. Results revealed radiation-induced
increment in lipid peroxidation in lungs (Figure 7).
Lipid peroxidation (LP) results from a cascade of events
induced by radiation in biological membranes. FS diet
led to a significant drop off in the LP levels in all the
FS-fed experimental mouse groups. Some reports show
that other plant extracts also decrease radiation-induced
LP [36]. Recent work by Gauter-Fleckenstein et al. [37]
showed mitigation of radiation-induced oxidative lung
tissue changes by an superoxide dismutase (SOD)
mimetic, although beneficial effects of the mitigator
were limited. Oxidative stress in lungs was only then
mitigated when the SOD mimetic was given up to 24
hours post radiation and not when given days (3 days)
or weeks (8 weeks) post irradiation. In our work the
Figure 9 Histological evaluation of lung Trichrome-stained sections post-XRT (4 months). Mice were fed with 0% or 10%FS diet prior (-3
weeks) or post (+2, +4, +6 weeks) XRT. Lungs were harvested 4 months post single fraction XRT and processed for histology. Arrows designate
collagen deposition in lung (blue color).
Christofidou-Solomidou et al. BMC Cancer 2011, 11:269
http://www.biomedcentral.com/1471-2407/11/269
Page 12 of 15drop in lipid peroxidation of lung tissues was significant
even when the FS diet was initiated 4 and 6 weeks post
radiation challenge. Further, our lab is currently explor-
ing dietary formulations of flaxseed components, to
identify the chief bioactive ingredient(s) that mitigate
radiation effects.
Radiation-induced inflammation is an important side
effect that contributes to normal tissue injury [7]. Our
results indicated that XRT-induced lung inflammation and
impaired blood oxygenation (decreased PaO2) were
improved with FS diet when initiated prior to or, impor-
tantly, days and weeks after XRT. Vujaskovic and cowor-
kers [38] have shown that severe hypoxia develops months
post an initial radiation exposure of lung tissues. Such
hypoxia contributes significantly to the development of a
cascade of events leading to lung injury. Improved blood
oxygenation of all FS-fed mouse groups (Figure 5C) may
lead to decreased levels of tissue hypoxia and may thus,
explain mitigation of adverse radiation effects even when
diets are initiated post challenge. In fact, recent work by
the same group [37] using an SOD mimetic to mitigate tis-
sue hypoxia, showed that this would be possible even when
given weeks post-irradiation, something which further cor-
roborates with our findings with the FS diet. Decrease of
radiation-induced lung inflammation by a mitigator has
never been shown. This is the first report that antioxidant
agents, such as the FS diets, mitigate pulmonary inflamma-
tion when given weeks post initial challenge.
A major feature of radiation pneumonitis is a consid-
erable increase in the alveolar protein exudates, an indi-
cator of increased vascular permeability and direct lung
injury [38]. Radiation causes damage to resident lung
cells which in turn release inflammatory mediators
(cytokines) and recruit inflammatory cells to the site
[39]. BAL protein level is the most direct and reliable
measure of lung injury, translating in actual tissue
damage while activation markers of lung tissue
inflammatory cell content such as the macrophage ED-1
marker, is a measure rather of inflammation and not
injury [37]. Our results show a significant mitigation of
lung injury in all the experimental FS diet fed groups,
regardless of the time of FS diet initiation. This may be
attributed to decreased inflammatory cell influx and
membrane oxidation in FS-supplemented mice. This is
the first report that an agent is reported to mitigate
Physsiological lung injury from radiation in vivo.
Radiation pneumonitis also involves irreversible fibrotic
changes in lung tissues occurring in the late phase of the
radiation response [40]. We have shown that wholegrain
FS was protective against experimental radiation fibrosis
[22]. Our current study showed for the first time that
fibrotic processes can be blunted in pulmonary tissues
even when the protective agent is given post-radiation
damage, i.e., as a radiation mitigator. Despite notable ben-
efits of a therapeutic usefulness of FS diet (i.e., when
initiated at 0, +2, +4 and +6 weeks post XRT), however,
the fact remained that FS-mediated decline in both lung
OH-Proline levels and FI was more prominent when diet
was started preventively, i.e., 3 weeks prior to XRT. This is
the first time that any botanical or chemical agent is indi-
cating mitigation of fibrotic changes effect in lungs.
Radiation exposure leads to histologically recognizable
chronic injury initiated by a series of molecular
responses involving a number of inflammatory cyto-
kines, pro-fibrotic cytokines and chemokines produced
by a variety of cell types, including macrophages, epithe-
lial cells and fibroblasts [27,39,41]. While many studies
in rodent thoracic irradiation models focus on cytokine
release during the initial post-irradiation phase [41], stu-
dies such as those of Rubin et al. [39] analyzed the cyto-
kine profile in lungs during the late, chronic phase. In
the present study, we evaluated the effect of FS diet on
inflammatory cytokines in the late phase of thoracic
radiation-exposed mice. As expected, the cytokine levels
Table 1 Evaluation of cytokine levels in BAL of mice 4 months post-XRT
Treatment
Groups
IL-1b IL-4 IL-6 IL-12
(p40/p70)
IL-17 KC MIG MIP-1a VEGF
0%FS 26.7 ± 8.3 28.6 ± 6.3 21.0 ± 5.9 19.2 ± 3.1 0.6 ± 0.2 658.6 ± 39.3 15.3 ± 2.5 25.4 ± 7.8 26.6 ± 4.6
0%FS + XRT 12.1 ± 2.7 17.4 ± 1.0 66.0 ± 42.5 88.1 ± 18.2 0.4 ± 0.1 173.0 ± 47.0 11.4 ± 4.2 18.5 ± 3.7 43.9 ± 4.5
10%FS 14.4 ± 5.1 20.4 ± 2.3 16.6 ± 2.0 12.9 ± 1.3 0.4 ± 0.1 730.7 ± 58.4 14.6 ± 4.4 16.5 ± 3.0 21.1 ± 2.9
#
10%FS + XRT (0 Day) 12.4 ± 0.8 18.2 ± 0.3 20.4 ± 1.1
$ 51.1 ± 13.3
$ 0.6 ± 0.1 521.0 ± 165.0* 20.9 ± 4.9 13.3 ± 1.5 21.4 ± 3.8
#
10%FS + XRT (-3 wks) 14.7 ± 1.5 17.9 ± 0.6 28.0 ± 6.4 54.2 ± 13.6* 0.9 ± 0.3* 396.0 ± 49.3 14.8 ± 2.8 15.7 ± 1.6 16.9 ± 3.4
#
10%FS + XRT (+2 wks) 13.1 ± 2.9 15.9 ± 1.0 16.6 ± 1.7* 43.2 ± 7.9* 0.3 ± 0.1
§§ 380.5 ± 162.7 7.2 ± 2.0 14.5 ± 1.7 13.4 ± 1.3
#
10%FS + XRT (+4 wks) 7.4 ± 1.0 16.6 ± 0.6 13.0 ± 1.8* 16.2 ± 1.2
#§ 0.1 ± 0.0
§§ 444.0 ± 66.8 8.8 ± 1.6 10.0 ± 1.2 6.8 ± 2.2
#
10%FS + XRT (+6 wks) 7.7 ± 1.2 16.5 ± 0.9 15.3 ± 1.7
$ 26.8 ± 7.1
# 0.2 ± 0.0
§§ 264.7 ± 150.7 9.0 ± 4.8 10.0 ± 2.1 11.7 ± 1.8
#
Mice were fed with 0% or 10%FS diet prior (-3 weeks) or post (+2, +4, +6 weeks) X-ray radiation therapy (XRT) and sacrificed after 4 months. Lungs were lavaged
and cytokine levels in BAL were measured. Data is represented mean ± SEM of two independent experiments (n = 15 and 25 mice in non-irradiated and
irradiated groups, respectively). Values are mean ± SEM of two independent experiments. n = 15 and 25 in non irradiated and irradiated groups respectively.
$p ≤ 0.05, *p ≤ 0.01,
#p ≤ 0.0005, for 0%FS irradiated vs. 10%FS irradiated groups.
§p ≤ 0.05,
§§ p ≤ 0.01 for 10%FS given preventively to XRT Vs 10%FS started therapeutically post-XRT.
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Page 13 of 15of the lung tissues and fluids measured in our model
reflect levels comparable to those in chronic inflamma-
tion and not in acute responses. Several cytokines asso-
ciated with inflammation were significantly lower in
irradiated FS-fed mice as compared to irradiated mice
on control diet, while no other cytokines were signifi-
cantly aggravated by the FS diet. Our studies show, for
example, a sustained 3-fold increased BAL level of IL-6
in radiation-exposed mice if fed a control diet while
dietary supplementation of flaxseed, given even weeks
post initial insult, decreased IL-6 levels, reflecting a low
inflammatory state of lung tissues.
Radiation-induced pulmonary injury consists of an
early latent period followed by chronic inflammation
that leads to collagen deposition and ultimately to fibro-
sis. Studies suggest that chronic inflammation occurs
due to the release of cytokines, chemokines, growth fac-
tors and it induces the development of fibrosis. Rubin et
al. [39] reported that a perpetual cascade of cytokines
activated soon after radiation exposure that leads to late
pulmonary fibrosis.
In the present study we also evaluated the effect of FS
diet on inflammatory cytokines in radiation-exposed
murine models. Macrophage inflammatory protein 1-a
(MIP-1a) appears to be an important cytokine mediator
of pulmonary inflammation and injury. Growing pre-
clinical and clinical data suggest a potential relationship
between serum MIP-1a levels and the risk of lung injury
following thoracic radiation.
Increased production of IL-6 is known to occur in the
chronic inflammation scenario. It stops production of
TNF-a, an acute phase inflammatory cytokine, and is
found in chronic disease conditions like thyroditis and
type I diabetes. Our studies also show a high level of IL-
6 in radiation-exposed mice. Dietary supplementation of
flaxseed decreased IL-6 levels, indicating a low inflam-
matory state. Both IL-4 and IL-17 are known to induce
IL-6 production. However in our study, the increase in
IL-6 in radiation exposed mice cannot be attributed to
IL-17 and IL-4 as both these cytokines showed lower
expression as compared to untreated controls.
IL-12 is an inducer of cell mediated inflammation. In
our studies, decreased IL-4 expression in radiation
exposed mice was concomitant with increase in IL-12
expression. This antagonistic nature of IL-4 and IL-12 is
well reported in literature. When flaxseed was given
therapeutically or preventively to irradiated mice, it led
to a decrease in IL-12 expression without changing IL-4
status. Flaxseed thus seems to decrease cell mediated
inflammation by decreasing IL-12 levels although it does
not have any effect on IL-4.
VEGF is identified as an endothelial cell specific
growth factor that contributes to angiogenesis and vas-
cular permeability. Radiation exposure to lungs induces
hypoxia [42] and hypoxia itself induces ROS generation
which in turn promotes inflammation and vascular
damage, activates pro-fibrotic cytokines, and promotes
collagen formation. Our results corroborate these
reports, as we observed increased VEGF levels in the
BAL fluid of radiation-exposed mice, while in FS-fed
irradiated animals low VEGF levels were observed as
compared to untreated controls.
Conclusion
Because radiation damage is a multi-faceted phenom-
enon, any agent or compound that can modify or alter
multiple aspects or mechanisms of radiation-induced
inflammation and fibrosis while at the same time being
both inexpensive and non-toxic is extremely exciting. It
is evident from our findings that dietary FS is a potential
agent in mitigating radiation damage and that the dis-
covery of the mitigating properties of FS may prove a
critical milestone in the development of non-toxic radia-
tion mitigators.
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